⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 30, 2007Cancer Biology & TherapyOpen Access

Targeting ROS: Selective killing of cancer cells by a cruciferous vegetable derived pro-oxidant compound

Xinjiang Wu Xianxin Hua

View Full Paper

Ask AI

Bookmark

Share

Abstract

Oncogenic transformation usually leads to increase of cellular reactive oxygen species (ROS) level that renders the cells vulnerable to additional ROS production. By targeting ROS, a naturally occurring ROS-inducing compound, beta-phenylethyl isothiocyanate (PEITC), selectively kills the transformed cells but not normal cells.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wu et al. (2007) studied this question.

synapsesocial.com/papers/6aae02a0ce2016d72f9f7c61 https://doi.org/10.4161/cbt.6.5.4092

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Sorting nexin 10 promotes triple-negative breast cancer progression through modulating cholesterol biosynthesis via stabilizing SREBP2Cancer Biology & Therapy · Mon,
2RecurIndex-derived molecular features associated with total pathological complete response in triple-negative breast cancer: An exploratory prospective cohort study with single-cell transcriptomic contextualizationCancer Biology & Therapy · Sat,
3ARHGAP40 suppresses clear cell renal cell carcinoma progression and is associated with altered glutamine-related metabolism and redox balanceCancer Biology & Therapy · Thu,
4UBE2S promotes gastric cancer progression through RACGAP1 stabilization associated with K292-dependent K63-linked ubiquitinationCancer Biology & Therapy · Thu,
5Inhibition of WNT signaling sensitizes CRC cells to anti-tumor effects of retinoids: basis for new drug combinations in oncologyCancer Biology & Therapy · Thu,

More from Cancer Biology & Therapy

Elevated miR-103b in exosomes derived from brain-metastatic triple-negative breast cancer cells remodels the brain pre-metastatic niche (PMN)Fri,
Synchronizing immunity and angiogenesis in lung adenocarcinoma: bridging biological synergy and clinical translationTue,
Thioredoxin reductase-1 facilitates cellular plasticity and stemness mediated by TGF-β1 in non-small cell lung cancerTue,
DNA-PKcs and PARP1 at the interface between DNA damage responses and cGAS–STING signaling: context-dependent roles and therapeutic implicationsTue,
The molecular mechanisms of platelets in tumor invasion and metastasis: a controversial roleTue,